Keyphrases
Fibroblast Growth Factor 23 (FGF23)
100%
African American Adolescents
100%
Adolescent Males
100%
Cardiac Mass
100%
Left Ventricular Mass
62%
Body Mass Index
50%
Obesity
37%
Blood Pressure
37%
Left Ventricular Hypertrophy
25%
Kidney Disease
12%
Hypertensive
12%
Novel Biomarkers
12%
Insulin
12%
Overweight or Obesity
12%
Complex Pathways
12%
Echocardiographic
12%
African American Men
12%
High-sensitivity C-reactive Protein (hs-CRP)
12%
Normal Weight
12%
Prehypertension
12%
Excess Adiposity
12%
Black Americans
12%
Mass Independent
12%
Multiple Linear Regression Analysis
12%
Nursing and Health Professions
Adolescent
100%
Fibroblast Growth Factor 23
100%
Heart Left Ventricle Mass
62%
Body Mass
50%
Heart Left Ventricle Hypertrophy
25%
Blood Pressure
25%
Kidney Disease
12%
Biological Marker
12%
C Reactive Protein
12%
Prehypertension
12%
Multiple Linear Regression Analysis
12%
Immunology and Microbiology
Fibroblast Growth Factor 23
100%
Heart Left Ventricle Mass
62%
Body Mass
50%
Blood Pressure
37%
Blood Plasma
12%
C-Reactive Protein
12%
Insulin
12%
Biochemistry, Genetics and Molecular Biology
Fibroblast Growth Factor 23
100%
Heart Left Ventricle Mass
62%
Body Mass
50%
Blood Pressure
37%
C-Reactive Protein
12%
Blood Plasma
12%
Medicine and Dentistry
Fibroblast Growth Factor 23
100%
Body Mass Index
50%
Blood Pressure
25%
Left Ventricular Hypertrophy
25%
Biological Marker
12%
Multiple Linear Regression Analysis
12%
Nephropathy
12%
C Reactive Protein
12%
Prehypertension
12%
Pharmacology, Toxicology and Pharmaceutical Science
Fibroblast Growth Factor 23
100%
Heart Left Ventricle Hypertrophy
25%
Biological Marker
12%
Kidney Disease
12%
C Reactive Protein
12%
Prehypertension
12%